TFRC and COVID-19: Our data revealed that individuals with COVID-19 displayed a distinct immune profile characterized by a predominance of monocytes expressing pro-inflammatory and regulatory markers, including TNFR2, co-expression of HLA-DR/TNFR2, and CD71.